Condition

Idiopathic Inflammatory Myopathies(IIM) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• LUCAR-G79D for adults with relapsed or refractory lupus or inflammatory muscle disease

  This trial will test an experimental CAR‑T cell treatment called LUCAR‑G79D in adults whose lupus or inflammatory muscle disease has returned or not responded to other treatments.

  Recruiting at 2 sites Phase 1 Nanjing Legend Biotech Co. · Bengbu, Anhui and 4 other locations · NCT07331272

• CD19/CD22/BCMA CAR‑T (BZE2204) for relapsed or refractory autoimmune diseases

  This will test whether a personalized CAR‑T cell therapy (BZE2204) targeting CD19, CD22, and BCMA can help adults with relapsed or refractory IIM, ITP, or SLE.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT07174843

Related topics

Quick answers

How many Idiopathic Inflammatory Myopathies(IIM) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →